Add BrightSurf on Google Email

LA BioMed


Increasing brain enzyme may slow Alzheimer's disease progression

A recent study published in Human Molecular Genetics found that increasing a brain enzyme called puromycin-sensitive aminopeptidase can remove toxic tau proteins from neurons. This removal restored neuronal density and slowed down disease progression without any adverse effects. The research suggests that elevating this naturally occur...

SourceLA BioMed·JournalHuman Molecular Genetics·DateFeb 16, 2011

LA BioMed researcher to receive prestigious honor

Dr. Casaburi will receive the award on Oct. 8 at the American Association of Cardiovascular and Pulmonary Rehabilitation's annual meeting in Milwaukee, recognizing his many contributions to the field of respiratory research and pulmonary rehabilitation. He is a leading researcher at LA BioMed, directing the Rehabilitation Clinical Tria...

1 of LA BioMed's founders to be honored

The American College of Physicians has awarded the Ralph O. Claypoole Sr. Memorial Award to Dr. Melvin R. Kaplan, one of LA BioMed's founders and a renowned internist. Dr. Kaplan has dedicated his career to patient care for over 60 years.

LA BioMed to launch study of testosterone in older men

A large national study on testosterone's effectiveness will be conducted at LA BioMed, focusing on its impact on anemia, cardiovascular disease, and other health conditions in older men with low testosterone levels. The Testosterone Trial will involve 800 men across 12 sites, including LA BioMed, to evaluate the treatment's benefits.

LA BioMed researcher finds clear racial discrepancies among patients with chronic kidney disease

A new study by LA BioMed researcher Rajnish Mehrotra found that black patients with early-stage chronic kidney disease are 78% more likely to die than whites. The study suggests that socio-economic factors such as poverty, lack of education and medical insurance contribute to the higher mortality rates among blacks.

SourceLA BioMed·JournalJournal of the American Society of Nephrology·DateMay 19, 2008

Pioneer of paramedic model to be honored

Dr. Criley developed the paramedic model in 1969, training firefighters to provide emergency care to heart attack victims. The program was later adopted nationwide, thanks in part to a TV show about it, and continues to save lives today.

LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies

A recent study published in Archives of Internal Medicine found that combined hormone therapy significantly increases the risk of abnormal mammograms and breast biopsies, compromising their diagnostic performance. The research involved 16,608 post-menopausal women and revealed a four percent greater risk of mammogram abnormalities afte...

SourceLA BioMed·JournalArchives of Internal Medicine·DateFeb 25, 2008

No reliable risk factors found for CA-MRSA

Studies by LA BioMed researchers found that close contacts of patients with CA-MRSA infection may be at higher risk of acquiring an infection. The findings suggest that CA-MRSA strains are more transmissible than traditional S. aureus strains, emphasizing the need for cautious treatment and contact isolation.

SourceLA BioMed·JournalClinical Infectious Diseases·DateFeb 6, 2007

Hospital disaster preparedness in Los Angeles County

The study found that most LA County hospitals have limited disaster preparedness, with only 16% integrating emergency services in their plans. The researchers highlight the need for integration of hospital disaster plans with EMS and community resources to ensure effective response to disasters.

SourceLA BioMed·JournalAcademic Emergency Medicine·DateOct 16, 2006

Manual vs device-assisted CPR

The LBD-CPR device's effectiveness is influenced by its use details, including patient population selection and deployment timing. Out-of-hospital cardiac arrests claim over 1,000 daily US lives.

SourceLA BioMed·JournalJAMA·DateJun 13, 2006

REI medical/research briefs

Despite a growing need for new antibiotics, only six are being developed out of 506 drugs, with FDA approvals declining by 56% over the past 20 years. Researchers have identified a novel structural signature in antimicrobial peptides that could accelerate development of new treatments.

SourceLA BioMed·JournalClinical Infectious Diseases·DateMay 3, 2004